ARYx Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2005
2006
2007
2008
2009
Cash & Short Term Investments
26,341.00
50,308.00
63,266.00
44,737.00
7,912.00
Total Accounts Receivable
-
45.00
-
-
-
Other Current Assets
1,375.00
1,058.00
1,633.00
1,113.00
895.00
Total Current Assets
27,716.00
51,411.00
64,899.00
45,850.00
8,807.00
Net Property, Plant & Equipment
4,143.00
4,169.00
3,655.00
3,198.00
2,258.00
Total Investments and Advances
1,093.00
903.00
903.00
1,203.00
1,003.00
Long-Term Note Receivable
-
20.00
-
-
-
Other Assets
360.00
261.00
168.00
897.00
338.00
Total Assets
33,312.00
56,764.00
69,625.00
51,148.00
12,406.00
ST Debt & Current Portion LT Debt
2,244.00
3,197.00
3,536.00
3,404.00
4,850.00
Accounts Payable
656.00
691.00
1,369.00
2,454.00
685.00
Other Current Liabilities
4,846.00
7,639.00
8,552.00
5,161.00
3,146.00
Total Current Liabilities
7,746.00
11,527.00
13,457.00
11,019.00
8,681.00
Long-Term Debt
8,921.00
6,679.00
3,444.00
11,278.00
5,588.00
Other Liabilities
2,378.00
21,605.00
17,377.00
1,436.00
1,053.00
Total Liabilities
19,045.00
39,811.00
34,278.00
23,733.00
15,322.00
Common Equity (Total)
67,088.00
93,712.00
35,347.00
27,415.00
2,916.00
Total Shareholders' Equity
67,088.00
16,953.00
35,347.00
27,415.00
2,916.00
Total Equity
67,088.00
16,953.00
35,347.00
27,415.00
2,916.00
Liabilities & Shareholders' Equity
33,312.00
56,764.00
69,625.00
51,148.00
12,406.00
Preferred Stock (Carrying Value)
-
110,665.00
-
-
-
About ARYx Therapeutics
View Profile
